Robyn Koeppen, MD
Family Medicine · Charlotte, NCNPI 1902242902
Payments from drug & device makers
Across 62 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$223
- GSK$115
- Gilead$114
- Amgen$89
- Daiichi Sankyo Inc.$85
- Genentech USA, Inc.$53
- plus $547 from 21 others
What the payments were for
- Food & beverage$1,226100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $223 |
| GSK | 2 | $115 |
| Gilead | 1 | $114 |
| Amgen | 5 | $89 |
| Daiichi Sankyo Inc. | 5 | $85 |
| Genentech USA, Inc. | 3 | $53 |
| Johnson & Johnson | 3 | $45 |
| Radius Health, Inc. | 2 | $44 |
| Eisai Inc. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $40 |
| Lilly USA, LLC | 3 | $33 |
| Neos Therapeutics, LP | 2 | $33 |
| Pfizer | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| AbbVie(2 entities) | 2 | $25 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Organon | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Cranial Technologies, Inc | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,226 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EnbrelEtanercept | 12 | $85,148 |
| MounjaroTirzepatide | 34 | $40,656 |
| EliquisApixaban | 13 | $18,741 |
| LinzessLinaclotide | 11 | $6,943 |
| Atorvastatin Calcium | 89 | $1,146 |
| ProgesteroneProgesterone, Micronized | 20 | $913 |
| Levothyroxine Sodium | 65 | $883 |
| Testosterone Cypionate | 15 | $777 |
| Rosuvastatin Calcium | 60 | $753 |
| Duloxetine Hcl | 30 | $712 |
| Baclofen | 22 | $606 |
| SynthroidLevothyroxine Sodium | 14 | $589 |
| ValacyclovirValacyclovir Hcl | 15 | $570 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $567 |
| Esomeprazole Magnesium | 12 | $561 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenEnbrel | $89 | $85,14812 claims |
| Lilly USA, LLCMounjaro | $33 | $40,65634 claims |
| PfizerEliquis | $31 | $18,74113 claims |
| AbbVieLinzess, Synthroid | $25 | $7,53225 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Charlotte
- George RaadCharlotte$7.7M
- Steven BauerCharlotte$2.7M
- Melissa JonesCharlotte$1.8M
- Laura LuptonCharlotte$811K
- Kevin SodenCharlotte$558K
- Joseph KonenCharlotte$322K
- Thomas BarringerCharlotte$305K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Jewell CarrCharlotte$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.